Pediatric Neurology
Volume 32, Issue 4 , Pages 221-228 , April 2005

Neurofibromatosis 1: From lab bench to clinic

  • Beth Ann Ward, MD

      Affiliations

    • Department of Neurology, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • David H. Gutmann, MD, PhD

      Affiliations

    • Department of Neurology, Washington University School of Medicine, St. Louis, Missouri
    • Neurofibromatosis Program, St. Louis Children’s Hospital, St. Louis Missouri
    • Corresponding Author InformationCommunications should be addressed to: Dr. Gutmann; Department of Neurology; Washington University School of Medicine; Box 8111; 660 S. Euclid Avenue; St. Louis, MO 63110

Received 8 September 2004 ,Accepted 1 November 2004.

References 

  1. Friedman JM . Epidemiology of neurofibromatosis type 1 . Am J Med Genet . 1999;89:1–6
  2. Gutmann DH , Aylsworth A , Carey JC , et al.   The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 . J Am Med Assoc . 1997;278:51–57
  3. Benedict PH , Szabo G , Fitzpatrick TB , Sinesi SJ . Melanotic macules in Albright’s syndrome and in neurofibromatosis . J Am Med Assoc . 1968;205:618–626
  4. Obringer AC , Meadows AT , Zackai EH . The diagnosis of neurofibromatosis 1 in the child under the age of 6 years . Am J Dis Child . 1989;143:717–719
  5. Friedman JM . Neurofibromatosis 1 (Clinical manifestations and diagnostic criteria) . J Child Neurol . 2002;17:548–554
  6. Listernick R , Louis DN , Packer RJ , Gutmann DH . Optic pathway gliomas in children with neurofibromatosis 1 (Consensus statement from the NF1 optic pathway glioma task force) . Ann Neurol . 1997;41:143–149
  7. Listernick R , Charrow J , Greenwald M , Mets M . Natural history of optic pathway tumors in children with neurofibromatosis type 1 (A longitudinal study) . J Pediatr . 1994;125:63–66
  8. Listernick R , Charrow J , Gutmann DH . Intracranial gliomas in neurofibromatosis type 1 . Am J Med Genet . 1999;89:38–44
  9. North KN , Riccardi V , Samango-Sprouse C , et al.   Cognitive function and academic performance in neurofibromatosis 1 (Consensus statement from the NF1 Cognitive Disorders Task Force) . Neurology . 1997;48:1121–1127
  10. Ozonoff S . Cognitive impairment in neurofibromatosis type 1 . Am J Med Genet . 1999;89:45–52
  11. North K , Joy P , Yuille D , et al.   Neurology . 1994;44:878–883
  12. Denckla MD , Hofman K , Mazzocco MMM , et al.   Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis 1 . Am J Med Genet . 1996;67:98–102
  13. Joy P , Roberts C , North K , deSilva M . Neuropsychological function and MRI abnormalities in neurofibromatosis type 1 in childhood . Dev Med Child Neurol . 1995;37:906–914
  14. Hofman KJ , Harris EL , Bryan RN , Denckla MB . Neurofibromatosis type 1 (The cognitive phenotype) . J Pediatr . 1994;124(Suppl.):S1–S8
  15. Moore BD , Slopis JM , Schomer D , Jackson ER , Levy BM . Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis . Neurology . 1996;46:1660–1668
  16. Hyman SL , Gill DS , Shores EA , et al.   Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1 . Neurology . 2003;60:1139–1145
  17. Duffner PK , Cohen ME , Seidel FG , Shucard DW . The significance of MRI abnormalities in children with neurofibromatosis . Neurology . 1989;39:373–378
  18. Dunn DW , Ross KL . Magnetic resonance imaging evaluation of learning difficulties and motor incoordination in neurofibromatosis . Neurofibromatosis . 1989;2:1–5
  19. Legius E , Descheemaeker MJ , Steyaert J , et al.   Neurofibromatosis type 1 in childhood (Correlation of MRI findings with intelligence) . J Neurol Neurosurg Psychiatry . 1995;59:638–640
  20. Harkin JC . Pathology of nerve sheath tumors . Ann NY Acad Sci . 1986;486:147–154
  21. Waggoner DJ , Towbin J , Gottesman G , Gutmann DH . Clinic-based study of plexiform neurofibromas in neurofibromatosis 1 . Am J Med Genet . 2000;92:132–135
  22. Huson SM , Harper PS , Compston DAS . Von Recklinghausen neurofibromatosis (A clinical and population study in south-east Wales) . Brain . 1988;111:1355–1381
  23. Korf BR . Plexiform neurofibromas . Am J Med Genet . 1999;89:31–37
  24. Packer RJ , Gutmann DH , Rubenstein A , et al.   Plexiform neurofibromas in NF1 (Toward biologic based therapy) . Neurology . 2002;58:1461–1470
  25. Ferner RE , Gutmann DH . International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1 . Cancer Res . 2002;62:1573–1577
  26. Ferner RE , Lucas JD , O’Doherty MJ , et al.   Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 . J Neurol Neurosurg Psychiatry . 2000;68:353–357
  27. Cardona S , Schwarzbach M , Hins U , et al.   Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours . Eur J Surg Oncol . 2003;29:536–541
  28. North K . Neurofibromatosis type 1 . Am J Med Genet . 2000;97:119–127
  29. Easton DF , Ponder MA , Huson SM , Ponder BA . An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1) (Evidence for modifying genes) . Am J Hum Genet . 1993;53:305–313
  30. Marchuk DA , Saulino AM , Tavakkol R , et al.   cDNA cloning of the type 1 neurofibromatosis gene (Complete sequencing of the NF1 gene product) . Genomics . 1991;11:931–940
  31. Cawthon RM , Weiss M , Xu G , et al.   A major segment of the neurofibromatosis type 1 gene (cDNA sequence, genomic structure and point mutations) . Cell . 1990;62:193–201
  32. Viskochil D , Buchberg AM , Xu G , et al.   Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus . Cell . 1990;62:187–192
  33. DeClue JE , Cohen BD , Lowy DR . Identification and characterization of the neurofibromatosis type 1 gene product . Proc Natl Acad Sci USA . 1991;88:9914–9918
  34. Gutmann DH , Wood DL , Collins FS . Identification of the neurofibromatosis type 1 gene product . Proc Natl Acad Sci USA . 1991;88:9658–9662
  35. Datson MM , Scrable H , Norlund M , Sturbaum AK , Nissen LM , Ratner N . The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes . Neuron . 1992;8:415–428
  36. Side L , Taylor B , Cayouette M , et al.   Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders . N Engl J Med . 1997;336:1713–1720
  37. Bollag G , Clapp DW , Shih S , et al.   Loss of NF1 results in activation of the ras signaling pathway and leads to aberrant growth in haematopoietic cells . Nat Genet . 1996;12:144–148
  38. DeClue JE , Papageorge AG , Fletcher JA , et al.   Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis . Cell . 1992;69:256–273
  39. Lau N, Feldkamp MM, Roncari L, et al. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
  40. Feldkamp MM , Lau N , Provias JP , Gutmann DH , Guha A . Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1 (A pathological and molecular explanation) . J Neurosurg . 1996;84:867–873
  41. Sherman LS , Atit R , Rosenbaum T , Cox AD , Ratner N . Single cell ras-GTP analysis reveals altered ras activity in a single population of neurofibroma Schwann cells but not fibroblasts . J Biol Chem . 2000;275:30740–30745
  42. Gutmann DH , Donahoe J , Brown T , James CD , Perry A . Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas . Neuropathol Appl Neurobiol . 2000;26:361–367
  43. Xu G , O’Connell P , Viskochil D , et al.   The neurofibromatosis type 1 gene encodes a protein related to GAP . Cell . 1990;62:599–608
  44. Weiss B , Bollag G , Shannon K . Hyperactive Ras as a therapeutic target in Neurofibromatosis Type 1 . Am J Med Genet . 1999;89:14–22
  45. Bollag G , McCormick F . Regulators and effectors of ras proteins . Ann Rev Cell Biol . 1991;7:601–632
  46. Wittinghofer A . Signal transduction via ras . Biol Chem . 1998;379:933–937
  47. Xu GF , Lin B , Tanaka K , et al.   The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements IRA mutants of S. cerevisiae . Cell . 1990;63:835–841
  48. Cichowski K , Jacks T . NF1 tumor suppressor gene function (Narrowing the GAP) . Cell . 2001;104:593–604
  49. The I , Hannigan GE , Cowley GS , et al.   Rescue of Drosophila NF1 mutant phenotype by protein kinase A . Science . 1997;276:791–794
  50. Guo HF , The I , Hannan F , Bernards A , Zhong Y . Requirement of Drosophilia NF1 for activation of adenylyl cyclase by PACAP-like neuropeptides . Science . 1997;276:795–798
  51. Dasgupta B , Dugan L , Gutmann DH . The Neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes . J Neurosci . 2003;23:8949–8954
  52. Huynh DP , Nechiporuk T , Pulst SM . Differential expression and tissue distribution of type 1 and type 11 neurofibromins during mouse fetal development . Dev Biol . 1994;161:538–551
  53. Brannan CI , Perkins AS , Vogel KS , et al.   Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues . Genes Dev . 1994;8:1019–1029
  54. Gitler AD , Epstein JA . Regulating heart development (The role of NF1) . Cell Cycle . 2003;2:96–98
  55. Zhu Y , Romero MI , Ghosh P , et al.   Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain . Genes Dev . 2001;15:859–876
  56. Atit RP , Crowe MJ , Greenhalgh DG , Wenstrup RJ , Ratner N . The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts . J Invest Dermatol . 1999;112:835–842
  57. Ingram DA , Yang FC , Travers JB , et al.   Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo . J Exp Med . 2000;191:181–187
  58. Nordlund ML , Rizvi TA , Brannan CI , Ratner N . Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains . J Neuropathol Exp Neurol . 1995;54:588–600
  59. Gutmann DH , Loehr A , Zhang Y , Kim J , Henkemeyer M , Cashen A . Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation . Oncogene . 1999;18:4450–4459
  60. Gutmann DH , Wu YL , Hedrick NM , Zhu Y , Guha A , Parada LF . Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes . Hum Mol Genet . 2001;10:3009–3016
  61. Bajenaru ML , Donahoe J , Corral T , et al.   Neurofibromatosis 1 heterozygosity results in a cell-autonomous growth advantage for astrocytes . Glia . 2001;33:314–323
  62. Guo HF , Tong J , Hannan F , Luo L , Zhong Y . A Neurofibromatosis-1-regulated pathway is required for learning in Drosophila . Nature . 2000;403:895–898
  63. Costa RM , Fererov NB , Kogan JH , et al.   Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 . Nature . 2002;415:526–530
  64. Jacks T , Shih TS , Schmitt EM , Bronson RT , Bernards A , Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in NF1 . Nat Genet . 1994;7:353–361
  65. Rutkowski JL , Wu K , Gutmann DH , Boyer PJ , Legius E . Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1 . Hum Mol Genet . 2000;12:1059–1066
  66. Muir D , Neubauer D , Lim IT , Yachnis AT , Wallace MR . Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells . Am J Pathol . 2001;158:501–513
  67. Perry A , Roth KA , Banerjee R , Fuller CE , Gutmann DH . NF1 deletions in S-100 protein positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors . Am J Pathol . 2001;159:57–61
  68. Zhu Y , Ghosh P , Charnay P , Burns DK , Parada LF . Neurofibromas in NF1 (Schwann cell origin and role of tumor environment) . Science . 2002;296:920–922
  69. Bajenaru ML , Hernandez MR , Perry A , et al.   Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity . Cancer Res . 2003;63:8573–8577
  70. DeClue JE , Heffelfinger S , Benvenuto G , et al.   Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models . J Clin Invest . 2000;105:1233–1241

PII: S0887-8994(04)00555-7

doi: 10.1016/j.pediatrneurol.2004.11.002

Pediatric Neurology
Volume 32, Issue 4 , Pages 221-228 , April 2005

Article Tools

* Image Usage & Resolution